60 DEGREES PHARMACEUTICALS, INC. (SXTP) Form 8-K — May 18, 2026
60 Degrees Pharmaceuticals, Inc. (SXTP) appointed Eric Francois to its Board of Directors, effective May 13, 2026. Francois brings over 20 years of experience in healthcare and life sciences, including prior roles as CFO of SCYNEXIS and Managing Director at Raymond James and Credit Suisse. He currently serves as an Independent Director of CERo Therapeutics Holdings (CERO) and has previously served on the board of Diffusion Pharmaceuticals (DFFN).
Key figures
- Capital raised by new director
- $300 million
Price after filing
1 day: -2.1%7 days: +3.5%30 days: +1.4%
Close on the filing date to close N calendar days later (from $1.44). Historical, not a forecast.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.